Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations

Exclusion Criteria

• •Subjects unable to meet inclusion requirements.
• •Women who are breastfeeding or pregnant.
• •Topical treatment during the last 7 days with corticosteroids or other immunosuppressive agents on or near the test area.
• •Systemic treatment during the last 7 days with corticosteroids (equivalent to \> 10 mg prednisone) or other immunosuppressive agents.
• •Treatment with ultraviolet (UV) light (including tanning) during the previous 3 weeks.
• •Acute dermatitis outbreak or dermatitis on or near the test area on the back.
• •Subjects unable to comply with patch test study requirements including multiple return visits and activity restrictions (e.g., protecting test panels from excess moisture due to showering or vigorous activity).
• •Subject participation in clinical trials of investigational drugs, treatments, or devices, other than T.R.U.E. TEST, during this study or 3 weeks prior to inclusion in this study.